![Greg Misson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Greg Misson is currently the Managing Director at Eqalis Pharmaceuticals Ltd.
He previously worked as the Executive Director & Chief Innovation Officer at Cannasouth Ltd.
Greg Misson active positions
Companies | Position | Start |
---|---|---|
Eqalis Pharmaceuticals Ltd
![]() Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Chief Executive Officer | - |
Former positions of Greg Misson
Companies | Position | End |
---|---|---|
CANNASOUTH LIMITED | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CANNASOUTH LIMITED | Health Technology |
Private companies | 1 |
---|---|
Eqalis Pharmaceuticals Ltd
![]() Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
- Stock Market
- Insiders
- Greg Misson